Skip to content

Clinical trials

Phase 2 Purpura, Thrombocytopenic, Idiopathic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Phase 2 Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20101
20141
20171
20181
20191
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris3
Novartis Pharmaceuticals2
Amgen1
GlaxoSmithKline1
Incyte Corporation1
University Hospital, Toulouse1
argenx1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic10
Aortic Arch Syndromes1
Arthritis, Rheumatoid1
Behcet Syndrome1
Cholangitis, Sclerosing1
Colitis, Ulcerative1
Crohn Disease1
Granulomatosis with Polyangiitis1
Hemorrhage1
Hepatitis, Autoimmune1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.